Literature DB >> 18768648

Phenotypic and genotypic characterization of verotoxin-producing Escherichia coli O103:H2 isolates from cattle and humans.

Musafiri Karama1, Roger P Johnson, Robert Holtslander, Carlton L Gyles.   

Abstract

Characterization of important non-O157 verotoxin-producing Escherichia coli (VTEC) has lagged considerably behind that of O157:H7 strains. This study characterized 91 VTEC O103:H2 strains from bovine and human sources and of North American and European origins by virulence or putative virulence genes, pulsed-field gel electrophoresis (PFGE) patterns, plasmid profiles, antimicrobial resistance, and colicin production. All strains were positive for vt1 and eae-epsilon; 97% were positive for ehxA; and all were negative for hlyA. Two strains carried vt2. There were 66 PFGE patterns grouped in six clusters, and there were 25 different plasmid profiles. Plasmid-encoded katP and etp genes were significantly more frequent in European than in North American human strains. The distribution of selected phenotypes was as follows: enterohemorrhagic E. coli (EHEC) hemolysin, 95%; colicin production, 38%; antimicrobial resistance, 58%. All the strains were negative for the alpha-hemolytic phenotype. In conclusion, the VTEC O103:H2 strains were diverse, as shown by PFGE, plasmid profiles, virulence markers, and antimicrobial resistance patterns, and all strains showed an EHEC hemolytic phenotype instead of the alpha-hemolytic phenotype that has been shown previously.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18768648      PMCID: PMC2576623          DOI: 10.1128/JCM.01095-08

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  43 in total

1.  Phenotypic and genotypic analyses of enterohemorrhagic Escherichia coli O145 strains from patients in Germany.

Authors:  Anne-Katharina Sonntag; Rita Prager; Martina Bielaszewska; Wenlan Zhang; Angelika Fruth; Helmut Tschäpe; Helge Karch
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

2.  Enteric infection of a goat with enterohemorrhagic Escherichia coli (O103:H2).

Authors:  G E Duhamel; R A Moxley; C W Maddox; E D Erickson
Journal:  J Vet Diagn Invest       Date:  1992-04       Impact factor: 1.279

3.  Epidemiology of sporadic diarrhea due to verocytotoxin-producing Escherichia coli: a two-year prospective study.

Authors:  C H Pai; N Ahmed; H Lior; W M Johnson; H V Sims; D E Woods
Journal:  J Infect Dis       Date:  1988-05       Impact factor: 5.226

4.  Characterization of Escherichia coli serotype O157:H7.

Authors:  S Ratnam; S B March; R Ahmed; G S Bezanson; S Kasatiya
Journal:  J Clin Microbiol       Date:  1988-10       Impact factor: 5.948

5.  Association of genomic O island 122 of Escherichia coli EDL 933 with verocytotoxin-producing Escherichia coli seropathotypes that are linked to epidemic and/or serious disease.

Authors:  Mohamed A Karmali; Mariola Mascarenhas; Songhai Shen; Kim Ziebell; Shelley Johnson; Richard Reid-Smith; Judith Isaac-Renton; Clifford Clark; Kris Rahn; James B Kaper
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

6.  A national surveillance of antimicrobial resistance in Escherichia coli isolated from food-producing animals in Japan.

Authors:  Mayumi Kijima-Tanaka; Kanako Ishihara; Ayako Morioka; Akemi Kojima; Tomoko Ohzono; Kaori Ogikubo; Toshio Takahashi; Yutaka Tamura
Journal:  J Antimicrob Chemother       Date:  2003-02       Impact factor: 5.790

7.  Toxin genotypes and plasmid profiles as determinants of systemic sequelae in Escherichia coli O157:H7 infections.

Authors:  S M Ostroff; P I Tarr; M A Neill; J H Lewis; N Hargrett-Bean; J M Kobayashi
Journal:  J Infect Dis       Date:  1989-12       Impact factor: 5.226

8.  Close association of verotoxin (Shiga-like toxin) production with enterohemolysin production in strains of Escherichia coli.

Authors:  L Beutin; M A Montenegro; I Orskov; F Orskov; J Prada; S Zimmermann; R Stephan
Journal:  J Clin Microbiol       Date:  1989-11       Impact factor: 5.948

9.  Production of toxins by Escherichia coli strains isolated from calves with diarrhoea in galicia (north-western Spain).

Authors:  J Blanco; E A González; S García; M Blanco; B Regueiro; I Bernárdez
Journal:  Vet Microbiol       Date:  1988-12       Impact factor: 3.293

10.  Shiga toxin-producing Escherichia coli infections associated with hemolytic uremic syndrome, Italy, 1988-2000.

Authors:  Alberto E Tozzi; Alfredo Caprioli; Fabio Minelli; Alessandra Gianviti; Laura De Petris; Alberto Edefonti; Giovanni Montini; Alfonso Ferretti; Tommaso De Palo; Maurizio Gaido; Gianfranco Rizzoni
Journal:  Emerg Infect Dis       Date:  2003-01       Impact factor: 6.883

View more
  4 in total

1.  Production of verotoxin and distribution of O islands 122 and 43/48 among verotoxin-producing Escherichia coli O103:H2 isolates from cattle and humans.

Authors:  Musafiri Karama; Roger P Johnson; Robert Holtslander; Carlton L Gyles
Journal:  Appl Environ Microbiol       Date:  2008-11-07       Impact factor: 4.792

2.  The highly virulent 2006 Norwegian EHEC O103:H25 outbreak strain is related to the 2011 German O104:H4 outbreak strain.

Authors:  Trine M L'Abée-Lund; Hannah J Jørgensen; Kristin O'Sullivan; Jon Bohlin; Goro Ligård; Per Einar Granum; Toril Lindbäck
Journal:  PLoS One       Date:  2012-03-05       Impact factor: 3.240

3.  Genomic comparison of Escherichia coli serotype O103:H2 isolates with and without verotoxin genes: implications for risk assessment of strains commonly found in ruminant reservoirs.

Authors:  Robert Söderlund; Julie Hurel; Tomas Jinnerot; Camilla Sekse; Anna Aspán; Erik Eriksson; Erik Bongcam-Rudloff
Journal:  Infect Ecol Epidemiol       Date:  2016-02-16

4.  Occurrence, characterization, and potential predictors of verotoxigenic Escherichia coli, Listeria monocytogenes, and Salmonella in surface water used for produce irrigation in the Lower Mainland of British Columbia, Canada.

Authors:  Justin Falardeau; Roger P Johnson; Franco Pagotto; Siyun Wang
Journal:  PLoS One       Date:  2017-09-27       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.